
Sign up to save your podcasts
Or


Joining the show for Medical Monday is Dr. Nakhle Saba to discuss CAR T-cell therapy, a groundbreaking cancer treatment offered by Our Lady of the Lake Health. CAR T uses a patient’s own immune cells, genetically reprogrammed to target and destroy cancer, offering a one-time, potentially curative option for several blood cancers. Dr. Saba explains how the therapy works, its FDA-approved uses, side effects like cytokine release syndrome, and the differences from traditional chemotherapy. He also highlights accessibility challenges and Louisiana’s pioneering role in CAR T trials.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Brian HaldaneJoining the show for Medical Monday is Dr. Nakhle Saba to discuss CAR T-cell therapy, a groundbreaking cancer treatment offered by Our Lady of the Lake Health. CAR T uses a patient’s own immune cells, genetically reprogrammed to target and destroy cancer, offering a one-time, potentially curative option for several blood cancers. Dr. Saba explains how the therapy works, its FDA-approved uses, side effects like cytokine release syndrome, and the differences from traditional chemotherapy. He also highlights accessibility challenges and Louisiana’s pioneering role in CAR T trials.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.